Enhancing the safety and efficacy of PSMA-based small-molecule drug conjugates by linker stabilization and conjugation to transthyretin binding ligand

TU Amin, R Emara, A Pal, H Aldawod… - Journal of Medicinal …, 2022 - ACS Publications
This work describes the enhancement of a novel antitumor therapeutic platform that
combines advantages from small-molecule drug conjugates (SMDCs) and antibody drug …
被引用次数：9 相关文章

Enhancing the Safety and Efficacy of PSMA-Based Small-Molecule Drug Conjugates by Linker Stabilization and Conjugation to Transthyretin Binding Ligand.

TU Amin, R Emara, A Pal, H Aldawod… - Journal of Medicinal …, 2022 - europepmc.org
This work describes the enhancement of a novel antitumor therapeutic platform that
combines advantages from small-molecule drug conjugates (SMDCs) and antibody drug …

Enhancing the Safety and Efficacy of PSMA-Based Small-Molecule Drug Conjugates by Linker Stabilization and Conjugation to Transthyretin Binding Ligand

TU Amin, R Emara, A Pal… - Journal of …, 2022 - pubmed.ncbi.nlm.nih.gov
This work describes the enhancement of a novel antitumor therapeutic platform that
combines advantages from small-molecule drug conjugates (SMDCs) and antibody drug …

[引用][C] Enhancing the Safety and Efficacy of PSMA-Based Small-Molecule Drug Conjugates by Linker Stabilization and Conjugation to Transthyretin Binding Ligand

TU Amin, R Emara, A Pal, H Aldawod, G Jiang… - Journal of Medicinal …, 2022 - cir.nii.ac.jp
Enhancing the Safety and Efficacy of PSMA-Based Small-Molecule Drug Conjugates by Linker
Stabilization and Conjugation to Transthyretin Binding Ligand | CiNii Research CiNii 国立情報学 …